Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.51 |
| ▸ | HPGD | P15428 | 1/20 | 0.51 |
| ▸ | CDC25B | P30305 | 2/20 | 0.50 |
| ▸ | CASP1 | P29466 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | CDC25A | P30304 | 1/20 | 0.47 |
| ▸ | CDC25C | P30307 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | LTC4S | Q16873 | 1/20 | 0.46 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25156303 | 1.00 | KMT2A (0.52) | KMT2AMEN1ALDH1A1HPGDCDC25B | |
| SCHEMBL15203285 | 1.00 | KMT2A (0.52) | KMT2AMEN1ALDH1A1HPGDCDC25B | |
| SCHEMBL1433197 | 0.85 | ALDH1A1 (0.53) | KMT2AALDH1A1HPGDCDC25BCDC25A | |
| SCHEMBL10412730 | 0.84 | ALDH1A1 (0.51) | KMT2AALDH1A1HPGDCDC25BCASP1 | |
| SCHEMBL12930749 | 0.84 | TRPV1 (0.46) | KMT2AMEN1ALDH1A1HPGDCASP1 | |
| SCHEMBL10920938 | 0.83 | CASP1 (0.49) | KMT2AMEN1ALDH1A1CASP1LMNA | |
| SCHEMBL16811757 | 0.83 | CASP1 (0.49) | KMT2AMEN1ALDH1A1CASP1LMNA | |
| SCHEMBL27351323 | 0.83 | CASP1 (0.65) | KMT2AMEN1ALDH1A1HPGDCASP1 | |
| SCHEMBL12930794 | 0.83 | MEN1 (0.43) | KMT2AMEN1HPGDCASP1TSHR | |
| SCHEMBL4023300 | 0.83 | TRPV1 (0.46) | KMT2AMEN1ALDH1A1TSHRLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250025443-A1 | COMPOUNDS AND METHODS FOR TREATING CORONA VIRUSES | Clear Creek Bio, Inc. (US) | 2025-01-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250025443-A1 | COMPOUNDS AND METHODS FOR TREATING CORONA VIRUSES | ACE, PREP, PEPD | KMT2A 1791/4885MEN1 4188/4885ALDH1A1 2460/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.